Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Cash from Operations (2020 - 2025)

Historic Cash from Operations for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to -$6.6 million.

  • PROCEPT BioRobotics' Cash from Operations rose 6470.74% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$71.0 million, marking a year-over-year increase of 2244.83%. This contributed to the annual value of -$99.2 million for FY2024, which is 813.87% up from last year.
  • According to the latest figures from Q3 2025, PROCEPT BioRobotics' Cash from Operations is -$6.6 million, which was up 6470.74% from -$15.0 million recorded in Q2 2025.
  • Over the past 5 years, PROCEPT BioRobotics' Cash from Operations peaked at -$6.6 million during Q3 2025, and registered a low of -$35.9 million during Q1 2023.
  • Moreover, its 5-year median value for Cash from Operations was -$18.2 million (2022), whereas its average is -$20.2 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first tumbled by 9707.09% in 2023, then surged by 6470.74% in 2025.
  • Quarter analysis of 5 years shows PROCEPT BioRobotics' Cash from Operations stood at -$16.5 million in 2021, then tumbled by 52.79% to -$25.2 million in 2022, then increased by 1.51% to -$24.8 million in 2023, then plummeted by 30.65% to -$32.4 million in 2024, then surged by 79.52% to -$6.6 million in 2025.
  • Its Cash from Operations stands at -$6.6 million for Q3 2025, versus -$15.0 million for Q2 2025 and -$17.0 million for Q1 2025.